Table 3:

Secondary Outcomes: Overall Longitudinal and Focal Group Comparisons for Emotion Dysregulation with Intervention Dose Sample (N=146).^a

Emotion Dysregulation	Group Means by Time Mean (SD			Wald χ2 Group x Time	Differences in Change at 3, 6 and 12 Months Mean Difference in Change (95% CI)
	MABT	TAU	WHE	p value	Interval	MABT vs TAU	MABT vs WHE	WHE vs TAU
Difficulties in Emotion Dysregulation (DERS)b
Baseline	88.1 (28.2)	83.8 (27.3)	90.7 (30.0)	χ2 = 11.45; p = .08
3 months	74.1 (23.8)	83.6 (27.5)	89.9 (27.6)		Baseline - 3 months	−14.2 (−23.6 to −4.9)**	−13.8 (−24.3 to −3 3)**	−0.4 (−9.2 to 8.3)
6 months	74.4 (25.9)	75.9 (25.0)	82.8 (25.4)		Baseline - 6 months	−8.3 (−17.3 to 0.8)	−7.6 (−18.3 to 3.2)	−0.7 (−9.9 to 8.5)
12 months	76.5 (29:4)	75.6 (21.9)	81.1 (23.1)		Baseline - 12 months	−5.2 (−16.9 to 6.4)	−3.7 (−18.8 to 11.5)	−1.5 (−15.1 to 12.0)
Respiratory Sinus Arrhythmia (RSA)c
Baseline	5.35 (2.02)	5.52 (1.39)	5.45 (1.70)	χ2 = 68.96; p < .001
3 months	5.78 (1.57)	5.45 (1.52)	5.38 (1.52)		Baseline - 3 months	0.53 (0.36 to 0.70)***	0.57 (0.38 to 0.77)***	−0.4 (−0.23 to 0.15)
6 months	5.64 (1.69)	5.19 (1.454)	5.33 (1.94)		Baseline - 6 months	0.29 (0.10 to 0.47)**	0.19 (−0.02 to 0.41)	0.09 (−0.11 to 0.30)
12 months	5.785 (1.95)	5.52 (1.351)	4.95 (1.92)		Baseline - 12 months	.44 (0.25 to 0.64)***	.72 (0.48 to 0.95)***	−0.27 (−0.50 to −0.05)**

Note:

^*p < .05;

^**p < .01;

^***p < .001. Groups: MABT=Mindful Awareness in Body-Oriented Therapy; TAU=Treatment as Usual; WHE=Women’s Health Education.

^aEstimates from multilevel mixed effects models.

^bIntervention dose sample sizes at baseline, 3, 6, and 12 months: MABT (47, 46, 40, 41); TAU (66, 59, 55, 54); WHE (32, 32, 30, 26).

^cIntervention dose sample sizes at baseline, 3, 6, and 12 months: MABT (47, 45, 34, 31); TAU (66, 52, 47, 43); WHE (32, 29, 24, 18).